Jazz Pharmaceuticals (JAZZ)

NASDAQ: JAZZ · Real-Time Price · USD

117.19

0.23 (0.20%)

At close: May 01, 2025, 3:59 PM

115.39

-1.54%

After-hours: May 01, 2025, 05:47 PM EDT

Jazz Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	2.41B	1.51B	881.48M	591.45M	1.06B	637.34M	309.62M	386.04M	365.96M
Short-Term Investments	580M	120M	30M	n/a	1.07B	440M	515M	215M	60M
Long-Term Investments	n/a	4.7M	5.5M	12.03M	5.24M	7.43M	9.59M	7.67M	9.74M
Other Long-Term Assets	123.97M	69.24M	58.89M	40.81M	25.72M	47.91M	42.7M	16.42M	14.06M
Receivables	716.76M	705.79M	651.49M	563.36M	396.49M	355.99M	263.84M	224.13M	234.24M
Inventory	480.44M	597.04M	714.06M	1.07B	95.4M	78.61M	52.96M	43.24M	34.05M
Other Current Assets	261.54M	320.81M	267.19M	252.39M	152.49M	78.89M	67.57M	76.69M	29.31M
Total Current Assets	4.63B	3.44B	2.61B	2.61B	2.84B	1.63B	1.23B	968.28M	748.07M
Property-Plant & Equipment	227M	234.99M	301.38M	343.42M	257.1M	270.89M	200.36M	170.08M	107.49M
Goodwill & Intangibles	6.47B	7.17B	7.49B	8.98B	3.15B	3.36B	3.66B	3.93B	3.91B
Total Long-Term Assets	7.38B	7.96B	8.23B	9.69B	3.7B	3.91B	3.97B	4.16B	4.05B
Total Assets	12.01B	11.39B	10.84B	12.3B	6.54B	5.54B	5.2B	5.12B	4.8B
Account Payables	77.87M	102.75M	90.76M	100.3M	26.95M	47.55M	40.6M	24.37M	22.41M
Deferred Revenue	n/a	n/a	463K	2.09M	2.55M	4.72M	5.41M	8.62M	1.12M
Short-Term Debt	31M	604.95M	31M	31M	246.32M	33.39M	33.39M	40.6M	36.09M
Other Current Liabilities	896.17M	142.32M	644.07M	491.67M	235.67M	176.67M	206.34M	143.85M	149.91M
Total Current Liabilities	1.04B	1.54B	933.19M	809.3M	653.75M	364.49M	345.49M	293.95M	257.41M
Long-Term Debt	38.94M	5.11B	5.69B	6.02B	1.85B	1.57B	1.56B	1.54B	1.99B
Other Long-Term Liabilities	6.13B	104.75M	106.81M	117M	101.15M	109.37M	218.88M	176.61M	112.62M
Total Long-Term Liabilities	6.88B	6.12B	6.82B	7.52B	2.22B	2.06B	2.1B	2.12B	2.67B
Total Liabilities	7.92B	7.66B	7.75B	8.33B	2.88B	2.43B	2.45B	2.41B	2.92B
Total Debt	6.16B	5.79B	5.8B	6.14B	2.23B	1.76B	1.6B	1.58B	2.03B
Common Stock	6K	61K	61K	61K	61K	61K	61K	61K	61K
Retained Earnings	1.13B	878.66M	733.59M	830.23M	1.16B	1.07B	841.05M	917.96M	528.91M
Comprehensive Income	-947.67M	-842.15M	-1.13B	-400.36M	-134.35M	-223.39M	-197.79M	-140.88M	-317.33M
Shareholders Equity	4.09B	3.74B	3.09B	3.97B	3.66B	3.11B	2.76B	2.71B	1.88B
Total Investments	580M	120M	35.5M	12.03M	1.07B	440M	515M	215M	60M